Huang DQ, Tran A, Yeh ML, Yasuda S, et al. Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase. Hepatology 2023 May 16. doi: 10.1097/HEP.0000000000000459.
PMID: 37184202